Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

42.15 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 42.15
Bid (Size) 36.88 (1)
Ask (Size) 45.00 (2)
Prev. Close 42.15
Today's Range 42.15 - 42.15
52wk Range 14.42 - 60.90
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Dive Into Twist Bioscience Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
7 mid-cap stocks with impressive gains last week: CDE, MPW, NGD, RH, AUR, TWST, ALHC. Positive news and financial results drove the surge. 
Via Benzinga

Performance

YTD
+21.68%
+21.68%
1 Month
+13.12%
+13.12%
3 Month
-13.89%
-13.89%
6 Month
+27.84%
+27.84%
1 Year
+127.84%
+127.84%

More News

Read More
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
From Twist Bioscience Corporation
Via Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
From Twist Bioscience Corporation
Via Business Wire
Evaluating Twist Bioscience: Insights From 5 Financial Analysts
Via Benzinga
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
From FN Media Group LLC
Via GlobeNewswire
3 Healthcare AI Stocks Positioned for Potential Breakthroughs
Via InvestorPlace
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Key Takeaways From Twist Bioscience Analyst Ratings
Via Benzinga
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
Sotera Health Posts Upbeat Results, Joins Thoughtworks, Sonic Automotive And Other Big Stocks Moving Higher On Monday
Via Benzinga
The 3 Best Med Tech Stocks to Buy Now
Via InvestorPlace
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Beats Q3 Earnings Forecast, Plans To Achieve 50% Gross Margin By Fiscal Year 2025
Via Benzinga
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
Via Talk Markets
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
Via Benzinga
Topics ETFs
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
From Twist Bioscience Corporation
Via Business Wire
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
Via Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.